We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
AVPR2
  • TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

AVPR2

Gene description

Arginine vasopressin receptor 2

Protein class

Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters

Predicted localization

Membrane

Number of transcripts

4
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Mixed
HPA (cell line):Cell line enhanced (EFO-21, SCLC-21H, U-698)
HPA (normal tissue):Tissue enhanced (adipose tissue)

Protein evidence

Evidence at protein level

Protein expression
normal tissue

Cytoplasmic and membranous expression mainly in renal tubules, adipocytes and smooth muscle cells.

ANTIBODY IHC RELIABILITY

Data reliability
description

Presumed off target binding observed and disregarded. Pending external verification.

Reliability score

Approved based on 1 antibody.
HPA046678
SHOW MORE

PROGNOSTIC SUMMARY

Gene product is not prognostic.
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Mixed

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Testis cancer

STAINING SUMMARY

HPA046678

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Cancer tissues showed weak to moderate cytoplasmic positivity and occasional nuclear staining. Extracellular positivity was observed in several cases. A few cases of testis cancer exhibited strong positivity. Cervix, skin and stomach cancer were negative.

GENE INFORMATION

Gene name

AVPR2 (HGNC Symbol)

Synonyms

DIR, DIR3, V2R

Description

Arginine vasopressin receptor 2 (HGNC Symbol)

Entrez gene summary

This gene encodes the vasopressin receptor, type 2, also known as the V2 receptor, which belongs to the seven-transmembrane-domain G protein-coupled receptor (GPCR) superfamily, and couples to Gs thus stimulating adenylate cyclase. The subfamily that includes the V2 receptor, the V1a and V1b vasopressin receptors, the oxytocin receptor, and isotocin and mesotocin receptors in non-mammals, is well conserved, though several members signal via other G proteins. All bind similar cyclic nonapeptide hormones. The V2 receptor is expressed in the kidney tubule, predominantly in the distal convoluted tubule and collecting ducts, where its primary property is to respond to the pituitary hormone arginine vasopressin (AVP) by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism. When the function of this gene is lost, the disease Nephrogenic Diabetes Insipidus (NDI) results. The V2 receptor is also expressed outside the kidney although its tissue localization is uncertain. When these 'extrarenal receptors' are stimulated by infusion of a V2 selective agonist (dDAVP), a variety of clotting factors are released into the bloodstream. The physiologic importance of this property is not known - its absence does not appear to be detrimental in NDI patients. The gene expression has also been described in fetal lung tissue and lung cancer associated with alternative splicing. [provided by RefSeq, Jul 2008]

Chromosome

X

Cytoband

q28

Chromosome location (bp)

153902531 - 153907166

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000126895 (version 83.38)

Entrez gene

554

UniProt

P30518 (UniProt - Evidence at protein level)

neXtProt

NX_P30518

Antibodypedia

AVPR2 antibodies

PROTEIN BROWSER

AVPR2-001
AVPR2-003
AVPR2-004
AVPR2-201

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

AVPR2-001
ENSP00000351805
ENST00000358927
P30518 [Direct mapping]
Vasopressin V2 receptor
Show all
Transporters
G-protein coupled receptors
   GPCRs excl olfactory receptors
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   GPCRHMM predicted membrane proteins
   # TM segments-based
   7TM proteins predicted by MDM
Disease related genes
FDA approved drug targets
   Biotech drugs
   Small molecule drugs
Show all
GO:0001992 [regulation of systemic arterial blood pressure by vasopressin]
GO:0003084 [positive regulation of systemic arterial blood pressure]
GO:0003091 [renal water homeostasis]
GO:0004930 [G-protein coupled receptor activity]
GO:0005000 [vasopressin receptor activity]
GO:0005515 [protein binding]
GO:0005622 [intracellular]
GO:0005768 [endosome]
GO:0005783 [endoplasmic reticulum]
GO:0005794 [Golgi apparatus]
GO:0005886 [plasma membrane]
GO:0005887 [integral component of plasma membrane]
GO:0006833 [water transport]
GO:0007186 [G-protein coupled receptor signaling pathway]
GO:0007188 [adenylate cyclase-modulating G-protein coupled receptor signaling pathway]
GO:0007190 [activation of adenylate cyclase activity]
GO:0007249 [I-kappaB kinase/NF-kappaB signaling]
GO:0007588 [excretion]
GO:0007599 [hemostasis]
GO:0008284 [positive regulation of cell proliferation]
GO:0010628 [positive regulation of gene expression]
GO:0016021 [integral component of membrane]
GO:0021537 [telencephalon development]
GO:0031398 [positive regulation of protein ubiquitination]
GO:0032609 [interferon-gamma production]
GO:0032870 [cellular response to hormone stimulus]
GO:0034097 [response to cytokine]
GO:0035811 [negative regulation of urine volume]
GO:0035814 [negative regulation of renal sodium excretion]
GO:0042277 [peptide binding]
GO:0045777 [positive regulation of blood pressure]
GO:0045907 [positive regulation of vasoconstriction]
GO:0055085 [transmembrane transport]
GO:1901652 [response to peptide]
Show all
371 aa
40.3 kDa
No 7
AVPR2-003
ENSP00000359066
ENST00000370049
P30518 [Direct mapping]
Vasopressin V2 receptor
Show all
Transporters
G-protein coupled receptors
   GPCRs excl olfactory receptors
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   GPCRHMM predicted membrane proteins
   # TM segments-based
   6TM proteins predicted by MDM
Disease related genes
FDA approved drug targets
   Biotech drugs
   Small molecule drugs
Show all
GO:0001992 [regulation of systemic arterial blood pressure by vasopressin]
GO:0003091 [renal water homeostasis]
GO:0004930 [G-protein coupled receptor activity]
GO:0005000 [vasopressin receptor activity]
GO:0005515 [protein binding]
GO:0005768 [endosome]
GO:0005783 [endoplasmic reticulum]
GO:0005794 [Golgi apparatus]
GO:0005886 [plasma membrane]
GO:0005887 [integral component of plasma membrane]
GO:0006833 [water transport]
GO:0007186 [G-protein coupled receptor signaling pathway]
GO:0007188 [adenylate cyclase-modulating G-protein coupled receptor signaling pathway]
GO:0007190 [activation of adenylate cyclase activity]
GO:0007588 [excretion]
GO:0007599 [hemostasis]
GO:0010628 [positive regulation of gene expression]
GO:0016021 [integral component of membrane]
GO:0031398 [positive regulation of protein ubiquitination]
GO:0032870 [cellular response to hormone stimulus]
GO:0042277 [peptide binding]
GO:0045907 [positive regulation of vasoconstriction]
GO:0055085 [transmembrane transport]
GO:1901652 [response to peptide]
Show all
309 aa
33.7 kDa
No 6
AVPR2-004
ENSP00000393513
ENST00000430697
C9JV81 [Direct mapping]
Vasopressin V2 receptor
Show all
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   GPCRHMM predicted membrane proteins
   # TM segments-based
   6TM proteins predicted by MDM
Show all
GO:0001992 [regulation of systemic arterial blood pressure by vasopressin]
GO:0004930 [G-protein coupled receptor activity]
GO:0005000 [vasopressin receptor activity]
GO:0007186 [G-protein coupled receptor signaling pathway]
GO:0016021 [integral component of membrane]
GO:0032870 [cellular response to hormone stimulus]
GO:0042277 [peptide binding]
GO:0045907 [positive regulation of vasoconstriction]
GO:1901652 [response to peptide]
Show all
372 aa
39.9 kDa
No 6
AVPR2-201
ENSP00000338072
ENST00000337474
P30518 [Direct mapping]
Vasopressin V2 receptor
Show all
Transporters
G-protein coupled receptors
   GPCRs excl olfactory receptors
Predicted membrane proteins
   Prediction method-based
   Membrane proteins predicted by MDM
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   Phobius predicted membrane proteins
   SCAMPI predicted membrane proteins
   SPOCTOPUS predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
   GPCRHMM predicted membrane proteins
   # TM segments-based
   7TM proteins predicted by MDM
Disease related genes
FDA approved drug targets
   Biotech drugs
   Small molecule drugs
Show all
GO:0001992 [regulation of systemic arterial blood pressure by vasopressin]
GO:0003091 [renal water homeostasis]
GO:0004930 [G-protein coupled receptor activity]
GO:0005000 [vasopressin receptor activity]
GO:0005515 [protein binding]
GO:0005768 [endosome]
GO:0005783 [endoplasmic reticulum]
GO:0005794 [Golgi apparatus]
GO:0005886 [plasma membrane]
GO:0005887 [integral component of plasma membrane]
GO:0006833 [water transport]
GO:0007186 [G-protein coupled receptor signaling pathway]
GO:0007188 [adenylate cyclase-modulating G-protein coupled receptor signaling pathway]
GO:0007190 [activation of adenylate cyclase activity]
GO:0007588 [excretion]
GO:0007599 [hemostasis]
GO:0010628 [positive regulation of gene expression]
GO:0016021 [integral component of membrane]
GO:0031398 [positive regulation of protein ubiquitination]
GO:0032870 [cellular response to hormone stimulus]
GO:0042277 [peptide binding]
GO:0045907 [positive regulation of vasoconstriction]
GO:0055085 [transmembrane transport]
GO:1901652 [response to peptide]
Show all
371 aa
40.3 kDa
No 7

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.